Tofunmi Oteju

Pharmacology Ph.D. | hIPSC-derived Models & Neuroimmunology Research

About

Tofunmi Oteju is a scientist trained in pharmacology and physiology with expertise in iPSC-based modeling, assay development, and translational research. She earned a Bachelor of Science in Biology from Augsburg University in 2021, where she began her research career as a Schizophrenia Research Assistant, gaining foundational experience in experimental design, data analysis, and neuroscience research. She is currently completing a Ph.D. in Pharmacology & Physiology at Drexel University College of Medicine and will **graduate in March**, specializing in neuroscience and NeuroHIV. Her doctoral work focuses on developing and characterizing human iPSC-derived models and functional assays to investigate inflammatory and viral mechanisms relevant to drug discovery and safety pharmacology. Alongside her studies, Tofunmi serves as an iPSC Development Consultant to biotechnology companies, collaborating with cross-functional teams to optimize stem cell workflows, evaluate translational fit, and support assay implementation for therapeutic programs. These experiences have strengthened her understanding of the drug development process and the interface between academic science and industry needs. Tofunmi’s interests center on neurodegenerative disease, innovative in vitro models, and precision medicine. She is driven by the goal of translating rigorous scientific research into therapies that improve patient outcomes.

Education

Drexel University College of Medicine

Ph.D. in Pharmacology and Physiology / 2026 (anticipated)

Augsburg University

B.S. in Biology / 2021

Experience

hIPSC Biotechnology Companies

hIPSC Development Consultant / May, 2024Present

Partnered with two hIPSC biotechnology companies to optimize human hIPSC culture and differentiation workflows for assay-ready disease models. Optimized hIPSC-derived systems to enhance inflammatory and HIV-relevant functional responses improving translational fidelity of in vitro platforms. Coordinated cross-functional evaluation of reproducibility, morphology, and functional performance across company and academic teams. Supported assay transfer characterization protocol standardization and technical documentation to enable consistent application of industry platforms.

Drexel University College of Medicine

Ph.D. Candidate - Neuroscience and NeuroHIV / May, 2021March, 2026

Investigated mechanisms by which addictive substances modulate HIV infection in the CNS using hIPSC-derived microglia macrophages and organoid models advancing understanding of NeuroHIV pathogenesis. Developed and characterized Novel Alternative Methods (NAMs) including hIPSC-derived microglia and organoid models with functional endpoints to evaluate pharmacologic and safety-relevant responses. Performed routine liquid handling maintenance and culture of hIPSC-derived and recombinant mammalian cells supporting assay reproducibility and medium-throughput workflows. Developed high-content imaging (96-well) and Python-based analysis pipelines that increased image analysis by 40% and enabled quantitative analysis of complex cell-virus interactions. Mentored and trained 5+ undergraduate and graduate researchers in cell culture and immunoassays accelerating project timelines and enhancing lab productivity. Assisted in managing a 500K annual research budget and supported grant proposal preparation contributing to multiple funded awards and securing 7K in competitive personal travel and research grants. Communicated findings at 15+ national and international conferences and published peer-reviewed papers.

Augsburg University Biology Department

Schizophrenia Research Assistant / May, 2020May, 2021

Investigated neural mechanisms underlying schizophrenia using primate models contributing to translational psychiatry research. Developed and implemented a Python-based program to analyze electrophysiological data across multiple brain regions streamlining data processing by 50%. Presented findings at 2 university-wide symposiums demonstrating ability to communicate complex psychiatric research to diverse scientific audiences.

Join Tofunmi on NotedSource!
Join Now

At NotedSource, we believe that professors, post-docs, scientists and other researchers have deep, untapped knowledge and expertise that can be leveraged to drive innovation within companies. NotedSource is committed to bridging the gap between academia and industry by providing a platform for collaboration with industry and networking with other researchers.

For industry, NotedSource identifies the right academic experts in 24 hours to help organizations build and grow. With a platform of thousands of knowledgeable PhDs, scientists, and industry experts, NotedSource makes connecting and collaborating easy.

For academic researchers such as professors, post-docs, and Ph.D.s, NotedSource provides tools to discover and connect to your colleagues with messaging and news feeds, in addition to the opportunity to be paid for your collaboration with vetted partners.

Expert Institutions
NotedSource has experts from Stanford University
Expert institutions using NotedSource include Oxfort University
Experts from McGill have used NotedSource to share their expertise
University of Chicago experts have used NotedSource
MIT researchers have used NotedSource
Proudly trusted by
Microsoft uses NotedSource for academic partnerships
Johnson & Johnson academic research projects on NotedSource
ProQuest (Clarivate) uses NotedSource as their industry academia platform
Slamom consulting engages academics for research collaboration on NotedSource
Omnicom and OMG find academics on notedsource
Unilever research project have used NotedSource to engage academic experts

Connect with researchers and scientists like Tofunmi Oteju on NotedSource to help your company with innovation, research, R&D, L&D, and more.